Pfizer at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
Pfizer takes part in 4 sessions at World Vaccine Congress Europe 2026 in Amsterdam. Its sessions range from next-generation vaccine technology and communication for vaccine uptake to maternal vaccine introduction in low- and middle-income countries. The most concrete is a Phase 2 study of the safety and immune response of an adjuvanted C. difficile vaccine in healthy adults.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
Pfizer New York, NY | |
Global pharmaceutical company with a vaccine portfolio spanning pneumococcal, RSV, COVID-19 and other infectious diseases. | Talk Tue Oct 20 09:00 The Technology Revolution: Agility for the Wave of Next Generation Vaccines Which newer vaccine platforms, such as RNA, could shorten outbreak response times and extend vaccines to cancer and autoimmune disease. Platforms & delivery Talk Wed Oct 21 12:00 Working Group: Quality Communication for Vaccine Literacy and Uptake Practical ways organizations can communicate clearly about vaccines to build trust and help people make informed decisions. Supply, safety & access Talk Wed Oct 21 15:15 Talk Wed Oct 21 15:30 |
Instantly find 20 buyers from Pfizer
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction